Volta
Toward targeted covalent inhibition of Cruzipain for the treatment of Chagas disease
Unknown authors
· 2026
hash_id: bc01cd7d61e43acf4392e3d3e9f5f041b875456838602e800e3abd9c3e6b19c5
· DOI: 10.1016/j.bmcl.2026.130744
Reference & gravity metrics
Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP
Secondary-market trade history
No secondary-market trades recorded for this Volta yet.
References (0)
No outbound references recorded.
Cited by (1)
| Challenges and Advances in the Simulation of Targeted Covalent Inhibitors Using… | secondary |